PlainRecalls

Hetero Labs, Ltd. - Unit III

Compiled from official public sources by the publisher.

5 recalls on record · Latest: Oct 3, 2018

Subscribe to new Hetero Labs, Ltd. - Unit III recalls (RSS)

Agency notice ledger

Federal filing book Hetero Labs, Ltd. - Unit III LIGHT-BOOK · SINGLE-AGENCY

#2,496 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,496 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Drug (5)
  • CAT drugs
  • CATS 2 categories
  • LATEST Oct 3, 2018
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Hetero Labs, Ltd. - Unit III accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Hetero Labs, Ltd. - Unit III compares to 14,151 recalling firms

Hetero Labs, Ltd. - Unit III ranks 2,496th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Hetero Labs, Ltd. - Unit III vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2496th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Hetero Labs, Ltd. - Unit III in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Hetero Labs, Ltd. - Unit III holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Oct 3, 2018

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
FDA Drug Moderate Aug 8, 2018

Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.
FDA Drug Moderate Feb 14, 2018

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30
FDA Drug Low Jan 24, 2018

Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero (trademark), Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-513-10
FDA Drug Moderate Dec 6, 2017

Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47

Hetero Labs, Ltd. - Unit III is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Apace Ky LLC 5 Astellas Pharma US Inc. 5 AstraZeneca Pharmaceuticals LP 5 Atlantic Management Resources Ltd. 5

Frequently Asked Questions

How many federal recall notices name Hetero Labs, Ltd. - Unit III? ▼
PlainRecalls indexes 5 distinct federal recall events naming Hetero Labs, Ltd. - Unit III, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Hetero Labs, Ltd. - Unit III sit among other recalling firms? ▼
Hetero Labs, Ltd. - Unit III ranks #2,496 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Hetero Labs, Ltd. - Unit III's notices? ▼
FDA Drug accounts for 5 of this firm's 5 indexed notices.
What product category dominates Hetero Labs, Ltd. - Unit III's filing book? ▼
Filings for Hetero Labs, Ltd. - Unit III span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Hetero Labs, Ltd. - Unit III: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Hetero Labs, Ltd. - Unit III; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026